SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is gaining significant community attention as investors anticipate the upcoming presentation of Phase 3 HAE trial data, which many hope will act as a major catalyst to trigger a short squeeze given the stock's high short interest. The community is actively debating the company's long-term value proposition as a potential one-time gene-editing cure, contrasting this against market skepticism and broader biotech sector volatility.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and community members react to reports of a proposed high-fee premium subscription model for early access to platform content. The conversation is heavily polarized, featuring intense debate over the platform's monetization strategy, broader geopolitical tensions involving Iran, and criticism regarding the company's financial transparency and political associations.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing renewed investor interest and community debate as participants weigh the impact of ecosystem expansion and potential regulatory shifts against concerns about historical volatility. Discussion remains polarized between long-term holders focusing on technical potential and critics emphasizing the token's past price performance.

TokenOS is the world’s most advanced AI-powered Web3 development platform, designed to turn natural language prompts into fully functional, production-ready blockchain applications. From simple tokens and memecoins to complex DeFi protocols, TokenOS automates the creation, deployment, and auditing of smart contracts and dApps with enterprise-grade reliability. By combining advanced language models with blockchain infrastructure, TokenOS removes the barriers of technical expertise, making Web3 development accessible to everyone. With instant deployment, built-in security best practices, and cross-chain support on the roadmap, TokenOS empowers entrepreneurs, developers, and creators to launch tokenized businesses and decentralized applications in seconds.

TokenOS AI

TokenOS AI is trending as investors react to its v4 launch and a revenue-sharing model that distributes decentralized GPU network earnings to stakers. The community is highlighting a significant supply shock, noting that a massive percentage of tokens are locked in long-term staking, leaving very little liquid supply for new buyers.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is trending as investors react to unprecedented phase 3 trial results where daraxonrasib doubled survival rates in pancreatic cancer patients, sparking discussions about a massive valuation surge and potential big-pharma buyout interest. While the community debates the timing of an acquisition and the impact of a recent equity offering, bullish sentiment remains strong driven by the potential for the company's RAS-targeted platform to become the new standard of care.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

Nasdaq is trending as investors debate the potential for a deeper correction following a period of high volatility and recent sell-offs in the tech sector. Community sentiment is divided, with some traders highlighting signs of market manipulation and bear traps while others closely watch institutional activity and technical indicators like the MACD and RSI for signs of a stabilization point.

Chipotle Mexican Grill, Inc. engages in the business of developing and operating restaurants that serve a relevant menu of burritos, burrito bowls, quesadillas, tacos, and salads made using fresh, high-quality ingredients. The company was founded by Steve Ells in 1993 and is headquartered in Newport Beach, CA.

Chipotle Mexican Grill

Chipotle Mexican Grill (CMG) is facing significant downward pressure as investors grow increasingly concerned about the brand's ability to maintain its premium pricing power, which has led to persistent community complaints regarding portion sizes and quality. The stock is currently hitting multi-year lows, driven by a wave of analyst downgrades, bearish technical sentiment, and broad investor frustration with management's perceived inability to address weakening foot traffic and consistent performance declines.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings is surging on news of a definitive 1 billion dollar all-stock acquisition agreement to purchase ACEA Pharma, triggering intense retail speculation about a massive short squeeze. Community discussion is dominated by the stock's low float and aggressive technical price targets, with bulls actively coordinating to hold the price despite frequent volatility-related trading halts.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

VanEck Gold Miners ETF ($GDX) is trending as traders closely watch key support levels near the 200-day moving average, with the community actively debating whether current weakness represents a final shakeout or the start of a deeper cyclical correction. Investors are particularly focused on how mining equities will respond to shifting Fed expectations, geopolitical tensions, and ongoing institutional gold buying despite broader market volatility.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending due to the company's announcement of a four-for-one stock split and strong quarterly performance that surpassed analyst expectations. Investors are actively debating the stock's premium valuation compared to cybersecurity peers, while the community continues to focus on the company's AI-driven growth narrative and its resilience in the face of ongoing sector rotation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
